Neutral summary of Henry Meds’ advertised compounded GLP-1 program. Pricing here is from secondary comparison data and has not been confirmed against the provider’s live site this cycle.
As of publication, GLP-1 Review Board has not established a referral relationship with Henry Meds. See our affiliate disclosure. Compensation, if any, would not affect this review or Henry Meds’s position in any list.
Provider data may change · advertised price · last checked 2026-06-25 · availability may vary by state and prescribing basis.
| Medication | Monthly | Prepaid | Provenance |
|---|---|---|---|
| Compounded tirzepatide | $179 | — | secondary / not re-verified |
A flat $179/month is reported as including medication, visits, supplies, and shipping (provider-stated, via secondary sources). Not confirmed on the live site this cycle.
• Membership: none reported (secondary).
• Shipping: reported included (secondary).
• Dose-increase: reported flat (secondary).
The FDA resolved the tirzepatide (Dec 2024) and semaglutide (Feb 2025) shortages, and wind-down deadlines passed in 2025. On Apr 30, 2026 the FDA proposed excluding these drugs from the 503B bulks list (comment closed Jun 29, 2026). Patient-specific 503A compounding continues only narrowly, and cost alone is not a clinical need. Full regulatory status →
Compounded semaglutide and tirzepatide are not FDA-approved and are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. The FDA does not review compounded drugs for safety, effectiveness, or quality before marketing. Primary source: FDA — Human Drug Compounding.
Secondary sources indicate a 503A pharmacy partner not named publicly — a transparency gap. Ask which pharmacy fills the prescription, its license/accreditation, and whether test results are available.
Secondary sources report ~41 states, excluding AL, AK, AR, HI, LA, MS, MO, SC, and WV. Not confirmed against the live site.
Availability may vary by state and prescribing basis; not independently confirmed state by state. Verify directly before enrolling.
We have not verified Henry Meds’ cancellation or refund terms. Review the provider’s Terms of Service directly.
• “All-inclusive flat price.” Provider-stated (secondary); confirm what’s included and whether it holds at higher doses.
• Any “generic” or “same as branded” framing would be a red flag per our safety guidance.
No. Compounded tirzepatide and semaglutide are not FDA-approved and are not the same as branded products.
Not this cycle. The $179 figure is from secondary sources and not confirmed on the live site; verify directly.
Update history. 2026-06 — initial profile from secondary data; live verification pending; no referral relationship at publication.